Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Trial and a Phase 2 Kidney Trial is Planned for 2017**



Namaste Enters Into Non-Binding LOI With CannMart, a Late Stage ACMPR Applicant

  • Namaste will purchase all of the issued and outstanding shares in the capital of CannMart, a late stage applicant under the Access to Cannabis for Medical Purposes Regulations
  • CannMart submitted its application to become a “sales only” licensed producer of medical cannabis


Hub On AGORACOM/ Read Release 

Message: Heavier than normal trading on the OTC for RVXCF

It would be nice to see Crestor/RVX208 unseat Lipitors best single year of sales of 19.1 billion.


tada,,,,it sure would be nice to garner even a % of that number.....the market builds here,,,,,,AZ is either some stupid and excecutive heads will roll down the road here upon sucess of BoM or they are looking to make a move at a certain milestone being achieved by RVX in the clinic!!!,,,,nothing else makes sense!!!.... jmo

New Message
Please login to post a reply